NEOPHARM
NEOPHARM, officially known as Neopharm Group, is a prominent player in the pharmaceutical industry, headquartered in Illinois, USA. Founded in 1998, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, primarily focusing on oncology, neurology, and rare diseases. With a strong operational presence across North America and Europe, NEOPHARM is recognised for its commitment to advancing patient care through unique drug formulations and cutting-edge therapies. The company’s core offerings include a range of specialty pharmaceuticals that are distinguished by their efficacy and safety profiles. NEOPHARM has achieved significant milestones, including strategic partnerships and successful product launches, solidifying its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does NEOPHARM's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NEOPHARM's score of 3 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NEOPHARM's reported carbon emissions
NEOPHARM, headquartered in Illinois, currently does not have publicly available carbon emissions data for the most recent year, nor do they specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed information, it is essential to monitor NEOPHARM's future disclosures regarding their climate commitments and any potential strategies they may implement to reduce their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NEOPHARM is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
